Literature DB >> 18585509

Correlates of late and very late thrombosis of drug eluting stents.

Gregory J Mishkel1, Anna L Moore, Steve Markwell, Marc E Shelton.   

Abstract

BACKGROUND: Late and very late thrombosis of coronary drug-eluting stents (DES) has received much attention but essentially remains unpredictable. We sought to identify correlates of stent thrombosis (ST) developing >30 days after DES implantation.
METHODS: We analyzed data from our single-center registry on 5,342 consecutive patients, who underwent a first DES implant between May 2003 and December 2006. The Academic Research Consortium definitions were applied to classify definite, probable, and possible ST. Cox regression analysis was performed to identify predictors of ST.
RESULTS: Follow-up information was obtained at 6 months and at 1, 2, and 3 years after DES implantation in 97.2%, 95.2%, 92.4%, and 89.8% of patients, respectively. We identified 34 patients who developed definite and 5 with probable ST >30 days after the index stent procedure. The 3-year cumulative incidence of definite and definite + probable ST >30 days was 1.33% and 1.50%, respectively. By Cox multiple variable regression, predictors of definite + probable ST were age (hazard ratio [HR] 0.95, 95% CI 0.92-0.98, P < .001), current smoking (HR 2.55, 95% CI 1.29-5.07, P = .007), prior percutaneous coronary intervention (HR 2.68, 95% CI 1.42-5.05, P = .002), "off-label" DES indication (HR 3.10, 95% CI 1.10-8.75, P = .032), bifurcation stenting (HR 2.37, 95% CI 1.40-3.99, P = .001), and stenting an occluded vessel (HR 3.02, 95% CI 1.59-5.74, P < .001).
CONCLUSIONS: We identified several baseline characteristics, which, when combined, may identify patients at risk for late-occurring ST, particularly after off-label DES placement.

Entities:  

Mesh:

Year:  2008        PMID: 18585509     DOI: 10.1016/j.ahj.2008.02.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.

Authors:  Piera Capranzano; George Dangas
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 2.  Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.

Authors:  Anthony Al-Dehneh; Hartaj Virk; Yazan Alkhouri; Aiman Hamdan; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2010

3.  Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry.

Authors:  Timm Bauer; Christoph A Nienaber; Ibrahim Akin; Karl-Heinz Kuck; Matthias Hochadel; Jochen Senges; Thomas Fetsch; Ulrich Tebbe; Stefan N Willich; Jürgen Stumpf; Georg V Sabin; Sigmund Silber; Gert Richardt; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2011-03-18       Impact factor: 5.460

Review 4.  Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis.

Authors:  Nso Nso; Mahmoud Nassar; Milana Zirkiyeva; Yolanda Mbome; Anthony Lyonga Ngonge; Solomon O Badejoko; Shahzad Akbar; Atika Azhar; Sofia Lakhdar; Laura M Guzman Perez; Yousef Abdalazeem; Vincent Rizzo; Most Munira
Journal:  Cureus       Date:  2022-04-09

5.  Noncardiac surgery for patients with coronary artery stents: timing is everything.

Authors:  Jeffrey J Rade; Charles W Hogue
Journal:  Anesthesiology       Date:  2008-10       Impact factor: 7.892

6.  Reduction in downstream test utilization following introduction of coronary computed tomography in a cardiology practice.

Authors:  Ronald P Karlsberg; Matthew J Budoff; Louise E J Thomson; John D Friedman; Daniel S Berman
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-05       Impact factor: 2.357

7.  Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography.

Authors:  Tian Feng; Chen Yundai; Liu Hongbin; Chen Lian; Sun Zhijun; Guo Jun; Jin Qinhua; Zhang Tao
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-13       Impact factor: 2.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.